Financials
- Market Capitalization 2.66 M
- Employee 2
- Founded 2007
- CEO N/A
- Website www.propanc.com
- Headquarter Delaware, United States
- FIGI BBG002086386
- Industry 医薬品メーカー(一般)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.09
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4759 | APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 4.42 USD | -13.84% | -42.75% | +105.58% | +237.40% | 6.67 M USD | ||
| 4846 | QCLS Q/C Technologies, Inc. - Common Stock | 0.56 USD | -3.45% | -21.13% | -65.00% | -85.42% | 4.59 M USD | ||
| 4916 | KAPA Kairos Pharma, Ltd. Common Stock | 0.80 USD | -3.61% | -33.33% | -53.22% | +37.93% | 2.71 M USD | ||
| 4921 | VIVS VivoSim Labs, Inc. - Common Stock | 0.18 USD | +5.88% | -10.00% | -37.93% | -90.58% | 2.67 M USD |